UBS Group

UBS Group’s Valuence Merger Corp. I Warrant VMCAW Stock Holding History

UBS Group’s Portfolio VMCAW Stock Details VMCAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-303	Closed	-$25	–	10095
2023 Q2	$25	Sell	303 -817	-73%	-$44	﹤0.01%	8672
2023 Q1	$49	Buy	+1,120	New	+$83	﹤0.01%	9342

Other funds holding VMCAW

Eisler Capital (US) New York $4.67B AUM 35.2% 1-Year Est. Return

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

UBS Group's VMCAW Position: Q3 2023 in Review

UBS Group sold out of Valuence Merger Corp. I Warrant (VMCAW) in Q3 2023, closing a stake of 303 shares — an estimated $25 sold.

UBS Group first reported a position in VMCAW in Q1 2023 and held it in 2 quarters. The position peaked at $49 in Q1 2023. 31 funds tracked by Wall St. Rank hold VMCAW as of Q3 2023.

UBS Group reported no remaining Valuence Merger Corp. I Warrant position as of Q3 2023 after selling out during the quarter.
UBS Group sold 303 Valuence Merger Corp. I Warrant shares in Q3 2023, an estimated $25.
UBS Group first reported a position in Valuence Merger Corp. I Warrant in Q1 2023 and held it in 2 quarters.
UBS Group's Valuence Merger Corp. I Warrant position peaked at $49 in Q1 2023.
31 funds tracked by Wall St. Rank held Valuence Merger Corp. I Warrant as of Q3 2023.

Based on UBS Group's 13F filing for Q3 2023, filed 9 Nov 2023.